Adiponectin and the systemic inflammatory response in weight-losing patients with non-small cell lung cancer

This publication has 13 references indexed in Scilit:

• Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex
  Diabetologia, 2003
• A LONGITUDINAL STUDY OF LEPTIN AND APPETITE, RESTING ENERGY EXPENDITURE AND BODY FAT MASS IN WEIGHT-STABLE CANCER PATIENTS
  Cytokine, 2002
• The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer
  British Journal of Cancer, 2002
• The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
  Nature Medicine, 2001
• The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
  Nature Medicine, 2001
• Insulin resistance in patients with cancer: relationships with tumor site, tumor stage, body-weight loss, acute-phase response, and energy expenditure
  Nutrition, 2001
• Cachexia
  Annals of Internal Medicine, 2000
• Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Prognostic Factors in Advanced Gastrointestinal Cancer Patients With Weight Loss
  Nutrition and Cancer, 2000
• Acute-Phase Proteins and Other Systemic Responses to Inflammation
  New England Journal of Medicine, 1999